Physical Wellness

Charlie Sheen Back On Medication After Seeking Alternative Medicine In Mexico

By Jenn Loro | Update Date: Jan 14, 2016 02:51 PM EST

In a pre-taped interview on the Dr. Oz Show, Hollywood actor Charlie Sheen revealed that he is resuming his conventional HIV medication after getting dismal results from an alternative treatment he was seeking in Mexico.

Crazy as it seems but the HIV positive actor appeared quite confident in presenting himself as his 'own guinea pig' when he deliberately went off his usual cocktail of HIV pills just to find medical relief on the other side of the border.

"I've been off my meds for about a week now," Sheen said. "Am I risking my life? Sure. So what? I was born dead. That part of it doesn't faze me at all," revealed Sheen as quoted saying by Fox News Latino.

In the TV segment, Sheen also said that he personally went to meet with Dr. Sam Chachoua whom he knew was working on a certain anti-HIV vaccine but could practice medicine in the US. He was hoping that with the Mexican doctor's vaccine formula, he might get some positive results.

Unfortunately, he was heading for a big disappointment.

"I'm a little off my game because right before I walked out here, I got some results I was disappointed about. I had been nondetectable . . . and checking the blood every week and then found out the numbers are back up", told Sheen as mentioned by The California Post.

Well, it appears that Sheen was not completely an idiot as he immediately went back to his usual meds after getting frustrated with alternative medication Mexican-style.

Equally matching his bravado was Mexican doctor whom he sought for the unconventional treatment.

"I drew some blood from him and I injected myself with it and I said, 'Charlie, if I don't know what I'm doing, then we're both in trouble now, aren't we?'", said Chachoua in a recorded phone interview with the TV host in an attempt to defend his treatment method he used on Sheen as stated in an article by Gawker.

© 2023 Counsel & Heal All rights reserved. Do not reproduce without permission.

Join the Conversation

Real Time Analytics